Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

Published:2010-09-25 Issue:12 Volume:14 Page:1859-1866
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Nasir Basil S.,Dozois Eric J.,Cima Robert R.,Pemberton John H.,Wolff Bruce G.,Sandborn William J.,Loftus Edward V.,Larson David W.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-010-1341-5.pdf

Reference18 articles.

1. Lictenstein GR, Hanauer SB, Sandborn WJ. ACG practice guidelines: Management of Crohn's Disease in Adults. Am J Gastroenterol 2009; 104:465–483

2. Solem CA, Loftus EV Jr. Management of refractory inflammatory bowel disease. Gastroenterol Clin N Am. 2004; 33:319–334

3. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease. N Engl J Med 2010; 362:1383-95

4. Sandborn WJ, Loftus EV. Balancing the risks and benefits of inflixmab in the treatment of inflammatory bowel disease. Gut. 2004; 53:780-782

5. Reguiiro M, Schraut W, Baidoo L, Kip KE, Sepluveda AR, Pesci M, Harrison J, Plevy SE. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenetrology 2009; 136(2):441-30

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-22

2. Biological therapy prior to repeat ileocolic resection in Crohn’s disease can reduce the postoperative complication rate;Techniques in Coloproctology;2022-09-29

3. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery;Gastroenterology;2022-07

4. Perioperative management of biologic agents in Crohn's disease;Seminars in Colon and Rectal Surgery;2022-03

5. Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn’s Disease After Elective Surgery: Meta-Analysis;Digestive Diseases and Sciences;2021-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3